Results 231 to 240 of about 80,998 (294)

Relapse risk prediction in patients with first-episode bipolar disorder: development, external validation, and pharmacotherapy associations of a machine learning model. [PDF]

open access: yesMol Psychiatry
Lieslehto J   +11 more
europepmc   +1 more source

Association between personality traits at return‐to‐work and future work continuation in employees returning from sick leave due to depression: A preliminary study

open access: yes
Psychiatry and Clinical Neurosciences Reports, Volume 4, Issue 4, December 2025.
Eiji Ikeda   +5 more
wiley   +1 more source

Comorbidity Between Recurrent Major Depressive Disorder and CADASIL: A Case Report With a Brief Review of Published Cases

open access: yesClinical Case Reports, Volume 13, Issue 11, November 2025.
ABSTRACT Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) may underlie mood disorders by directly affecting cerebral vascular function and neural networks, thereby contributing to or worsening mood symptoms.
Yi‐meng Wang   +3 more
wiley   +1 more source

Initial Manic Presentation in Creutzfeldt-Jakob Disease: A Case Report. [PDF]

open access: yesAm J Case Rep
Alotaibi FG   +3 more
europepmc   +1 more source

Unveiling Neuropsychiatric Lupus: A Case of SLE Presenting With Depressive Symptoms and Literature Review

open access: yesClinical Case Reports, Volume 13, Issue 11, November 2025.
ABSTRACT A young woman presented with a rare depressive‐onset manifestation and showed a poor response to antidepressant therapy. Subsequently, with the involvement of multiple organ systems, positive autoantibodies, and multiple lesions on head MRI, she was diagnosed with systemic lupus erythematosus (SLE).
Yuqiong He, Qiuxiang Ou, Li Zhang
wiley   +1 more source

Pharmacokinetics and Bioequivalence of a Novel Extended‐Release Formulation of Methylphenidate Hydrochloride for Attention‐Deficit/Hyperactivity Disorder

open access: yesClinical Pharmacology in Drug Development, Volume 14, Issue 11, Page 829-835, November 2025.
Abstract Extended‐release (ER) formulations of the stimulant methylphenidate are commonly used to treat attention‐deficit/hyperactivity disorder in both children and adults. Previous studies have shown that the clinical effectiveness of long‐acting methylphenidate formulations is closely tied to the drug's pharmacokinetic (PK) profile, highlighting the
Ann C. Childress   +2 more
wiley   +1 more source

Exposure–Response Analysis for Aripiprazole Once‐Monthly in Patients Diagnosed With Bipolar I Disorder

open access: yesClinical Pharmacology in Drug Development, Volume 14, Issue 11, Page 869-878, November 2025.
Abstract Aripiprazole once‐monthly (AOM) is approved for the maintenance monotherapy treatment of bipolar I disorder (BP‐I) in adults. A previously developed population pharmacokinetic model was validated by applying it to data from patients diagnosed with BP‐I.
Xiaofeng Wang   +10 more
wiley   +1 more source

‘What is Your Job?’: A Qualitative Analysis of the Deployment, Utilisation, and Contribution of Support Workers in Diagnostic Imaging Services in England

open access: yesThe International Journal of Health Planning and Management, Volume 40, Issue 6, Page 1220-1231, November 2025.
ABSTRACT Support workers (SWs) form the largest section of the NHS workforce, and the ongoing NHS workforce crisis underscores the need for their efficient utilisation. This study explored the deployment of imaging SWs within NHS radiology departments in England, forming part of a larger multiphase research project funded by the National Institute for ...
Sarah Etty   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy